NCT04871451Phase 2Completed

Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia

Study sponsor: AEON Biopharma, Inc. · AEON

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-07-24Actual
Enrollment · participants51Actual
Source updated2024-08-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview